Be a Smart Investor
Wednesday, February 22, 2017
We price drugs in line with innovation potential: Bayer CEO
“We price our drugs in line with their innovation potential and in line with the competitive environment,” Bayer's CEO told CNBC.
from Mergers and Acquisitions http://ift.tt/2loozJ6
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment